Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy

American Journal of Hypertension

Volumn 9, Issue 9, 1996, Pages 854-859

  Weir, Matthew R ^a   Prisant, L Michael ^b   Papademetriou, Vasilios ^c   Weber, Michael A ^d   Adegbile, Isaac A ^e   Alemayehu, Demissie ^e   Lefkowitz, Martin P ^e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^e WYETH RESEARCH   (United States)

Author keywords

Hypertension treatment; Quality of life

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BISOPROLOL; HYDROCHLOROTHIAZIDE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EDEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AMLODIPINE; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 0030250808     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00116-1     Document Type: Article

References (24)

1. 1. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
2. 2. Bulpitt CJ, Dollery CT, Carne S: Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976;38:121-128.
3. 3. Bulpitt CJ, Fletcher AE: Quality of life in hypertensive patients on different antihypertensive treatments: rationale for methods employed in a multicenter randomized controlled trial. J Cardiovasc Pharmacol 1985; 7:S137-S145.
4. 4. Jachuck SJ, Brierley H, Jachuck S, Wilcox PM: The effect of hypotensive drugs on the quality of life. J R Coll Gen Pract 1982;32:103-105.
5. 5. Najman JM, Levine S: Evaluating the impact of medical care and technologies on the quality of life; a review and critique. Soc Sci Med 1981;15:F105-F107.
6. 6. Levine S, Croog SH: What constitutes quality of life? A conceptualization of the dimensions of life quality in healthy populations and patients with cardiovascular disease, in Wenger NK, Mattson ME, Furberg CD, Elinson J (eds): Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, LeJacq Publishing, Inc., 1984, pp 46-58.
7. 7. Croog SH, Levine S, Testa MA, et al: The effects of antihypertensive therapy of quality of life. N Engl J Med 1986;314:1657-1664.
8. 8. Dahlof C: Well being (quality of life) in connection with hypertensive treatment. Clin Cardiol 1991;14:97-103.
9. 9. Hyemdahl P, Wiklund IK: Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? J Hypertens 1992;10:1437-1446.
10. 10. Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 1994; 272:619-626.
11. 11. Dupuy HJ: The psychological general well-being (PGWB) index, in Wenger NK, Mattson ME, Furberg CD, Elinson J (eds): Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, LeJacq Publishing, Inc., 1984, pp 170-183.
12. 12. Zung WWK: A self-rating depression scale. Arch Gen Psychiatr 1965;12:63-70.
13. 13. Zung WWK, Richards CB, Short MJ: Self-rating depression scale in an outpatient clinic. Arch Gen Psychiatr 1965;13:508-515.
14. 14. Kong BW, Clive J, Kong SH: Quality of life as a vital clinical sign. J Hum Hypertens 1990;4:121-132.
15. 15. Prisant LM, Weir MR, Papademitriou V, et al: Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995; 130:359-366.
16. 16. Shapiro AP, Miller RE, King E, et al: Behavioral consequences of mild hypertension. Hypertension 1982; 4:355-360.
17. 17. Chang SW, Fine R, Siegel D, et al: The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991;151:2402-2408.
18. 18. Neaton JD: The treatment of mild hypertension study: a randomized, placebo-controlled trial of nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991;151:1413-1423.
19. 19. Neaton JD, Grimm RH, Prineas RJ, et al: Treatment of mild hypertension study. JAMA 1993;270:713-724.
20. 20. Fletcher AE, Bulpitt CJ, Chase DM, et al: Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension 1992;19:499-507.
21. 21. Croog SH, Kong BW, Levine S, et al: Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Arch Intern Med 1990; 150:1733-1741.
22. 22. Applegate WB, Phillips HL, Schnaper H, Sheperd AMM: A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991;151:1817-1823.
23. 23. Fletcher AE, Chester PC, Hawkins CMA, et al: The effects of verapamil and nifedipine on quality of life in hypertension. J Hum Hypertens 1989;3:125-130.
24. 24. Fletcher AE, Bulpitt CJ, Hawkins CM, et al: Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens 1990;8:463-466.